High-Efficiency Postdilution Online Hemodiafiltration Reduces All-Cause Mortality in Hemodialysis Patients
This multicenter, open-label, randomized controlled trial randomized chronic hemodialysis patients to conventional hemodialysis or high-efficiency postdilution online hemodiafiltration (OL-HDF).
Patients assigned to OL-HDF had a 30% lower risk of all-cause mortality compared to those on conventional hemodialysis (hazard ratio [HR], 0.70; 95% confidence interval [95% CI], 0.53–0.92; P=0.01). In addition, the OL-HDF group had a 33% lower risk of cardiovascular mortality (HR, 0.67; 95% CI, 0.44–1.02; P=0.06) and a 55% lower risk of infection-related mortality (HR, 0.45; 95% CI, 0.21–0.96; P=0.03).
:
Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
Propensity-Matched Mortality Comparison of Incident Hemodialysis and Peritoneal Dialysis Patients
Source: Nephrology Now - Category: Urology & Nephrology Authors: Nephrology Now editors Tags: Hemodialysis Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Dialysis | Endocrinology | Heart | Hemodiafiltration | Hemodialysis | Peritoneal Dialysis | Tekturna | Urology & Nephrology